HAKA: Routine Follow-up at 10 Years After Hip- or Knee Arthroplasty: Wasting Resources or Appropriate Healthcare?

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorReinier Haga Orthopedisch Centrum

About this trial

After undergoing total hip or total knee arthroplasty, current guidelines recommend routine follow-up with an X-ray within 3 months and again at 1 year. Follow-up at 5 years (for hip arthroplasties) or every 5 years (for knee arthroplasties) is also considered worthwhile according to the guideline. However, these follow-up appointments require considerable time from patients, caregivers, and healthcare professionals, and it is unclear whether they are truly beneficial. It is possible that a single follow-up within 3 months is sufficient. This could potentially prevent over 100,000 unnecessary hospital visits per year, resulting in significant cost savings. If patients or healthcare providers have concerns, they can always request an additional follow-up.

The HAKA trial consists of three different work packages (WPs). This trial (WP2) investigates the 10-year follow-up, WP1 examines the 1-year follow-up, and WP3 is a qualitative study exploring the experiences and perceptions of patients and healthcare professionals. The aim of the HAKA trial is to safely reduce routine follow-up appointments after total hip or knee arthroplasty and to revise current clinical guidelines accordingly.

Eligibility criteria

Qualifiers

Underwent primary THA or TKA approximately 10 years ago

Age 50 years or older at time of THA or TKA

Capable and willing to complete questionnaires (when applicable)

Understanding Dutch or English

Disqualifiers

Other indication for surgery than osteoarthritis

Deceased

Revision arthroplasty of hip or knee, except a conversion from unicompartmental knee arthroplasty to TKA or from hip hemiarthroplasty/resurfacing to THA

Already participating in this study due to another hip or knee surgery

Trial design

Treatments tested in this trial

  • Routine Follow-Up (RFU)
  • Active Check-Up on Demand (ACOD)
  • Passive Check-Up on Demand (PCOD)

Treatment groups

1,500 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Reinier Haga Orthopedisch Centrum

Lead sponsor

JointResearch

Collaborator

Tergooi Medical Center

Collaborator